Cross-Border Access to Clinical Trials in the EU: Exploratory Study on Needs and Reality

Frontiers in Medicine
Teodora LalovaIsabelle Huys

Abstract

Objectives: To analyze the current situation of cross-border access to clinical trials in the EU with an overview of stakeholders' real-life experience, and to identify the needs, challenges, and potential for facilitation of cross-border access. Methods: We employed a mixed methods design. Semi-structured interviews and an online survey were conducted with a wide range of stakeholders: patient representatives, investigators/physicians, policy and regulatory experts, academic and commercial sponsor representatives, ethics committee members. Interviews underwent a framework analysis. The survey was analyzed descriptively. Results: Three hundred ninety six individuals responded to the survey. The majority were investigators/physicians (46%) and patient representatives (33%). Thirty eight individuals were interviewed. The majority were investigators/physicians (29%) and patient representatives (29%). All European regions were represented in the study. The highest response rate was received from residents of Western European countries (38% of survey respondents, 45% of interviewees), the lowest from Eastern Europe (9% of survey respondents, 5% of interviewees). The study suggested that cross-border participation in clinical trials ...Continue Reading

References

Jun 1, 1995·British Journal of Cancer·M SlevinN Thatcher
Jun 3, 2004·Journal of Medical Ethics·J P Bentley, P G Thacker
Feb 24, 2009·Quality & Safety in Health Care·R SuñolA Jacquerye
Nov 21, 2009·Social Science & Medicine·Cynthia E CryderGeorge Loewenstein
Oct 15, 2011·International Journal of Nursing Studies·Bernadette Dierckx de CasterléYvonne Denier
Jun 22, 2012·PLoS Medicine·Trudie Lang, Sisira Siribaddana
Sep 21, 2013·BMC Medical Research Methodology·Nicola K GaleSabi Redwood
Jul 30, 2014·American Heart Journal·Sabrina Bernardez-PereiraUNKNOWN Methodological Evaluation of clinical TriAls Study Group
Dec 31, 2015·BMC International Health and Human Rights·Raffaella RavinettoMinne Casteels
May 4, 2016·Perspectives in Clinical Research·Premnath Shenoy
May 25, 2016·The American Journal of Bioethics : AJOB·Avram DenburgSteven Joffe
Jun 13, 2017·Pharmacology Research & Perspectives·Tilde DombernowskySimon F Thomsen
Aug 3, 2017·Trials·Snezana DjurisicChristian Gluud
Jan 14, 2018·Contemporary Clinical Trials·Grant D HuangUNKNOWN CTTI Recruitment Project Team
Mar 2, 2016·Contemporary Clinical Trials Communications·Elaine Walsh, Ann Sheridan
Jul 23, 2019·Contemporary Clinical Trials·Luke GelinasBarbara E Bierer
Dec 4, 2019·Contemporary Clinical Trials Communications·M AntoniouA L Jorgensen

❮ Previous
Next ❯

Software Mentioned

EURACAN
Genturis
PaedCan
Skype®
NVivo®
EuroBloodNET
SAS
SurveyMonkey®
FindMeCure

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Emergency Nurse : the Journal of the RCN Accident and Emergency Nursing Association
Yazdan Cyrus Karbhari
The Medical Journal of Australia
Paul N ReynoldsPublic Health Association of Australia
European Journal of Human Genetics : EJHG
Pia PohjolaHelena Kääriäinen
Architectural Record
James S Russell
© 2021 Meta ULC. All rights reserved